Benzinga | Aug 9, 2021 04:44PM EDT

IGM Biosciences Q2 EPS $(1.16) Down From $(0.62) YoY

IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(1.16) per share. This is a 87.1 percent decrease over losses of $(0.62) per share from the same period last year.